Quick navigation menu :

  1. Go to the content
  2. Go to the main sections menu
  3. Go to the search engine
  4. Go to the help menu
  5. Go to the modules
  6. Go to the shortcuts list

Help menu :

  1. Sanofi Worldwide |
     
  2. US Web Sites |
     
  3. Global Business Websites |
     
  4. Contact us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Vermont Disclosure

Product Information Services

If you have any questions, please call
Tel: 800-633-1610

Content :

Guide to Vermont's pharmaceutical marketer price disclosure law

Warning

This information is intended for U.S. residents.

 

33 V.S.A. § 2005a.

Guide to Vermont's pharmaceutical marketer price disclosure law
Product NameShort FormLong FormDate updated
Aubagio® (teriflunomide)April 24, 2017
Cerdelga (eliglustat)April 24, 2017
Hectorol (doxercalciferol)April 24, 2017
Multaq (dronedarone)April 24, 2017
Renagel (sevelamer hydrochloride) / Renvela (sevelamer carbonate)April 24, 2017
Caprelsa (vandetanib)April 24, 2017

Please See Full Prescribing Information, including Boxed Warning, for Aubagio, Caprelsa and Multaq.



US.COR.16.11.003


Last update: April 24, 2017

Modules :